Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

9 Jun 2022 07:00

RNS Number : 2258O
Sopheon PLC
09 June 2022
 

SOPHEON PLC

 

("Sopheon" or the "Company")

 

AGM Statement

 

Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, holds its Annual General Meeting ("AGM") today. The Board takes this opportunity to give shareholders the following update and review of the business.

 

2021 in review

 

Our 2021 performance was gratifying both for the strategic progress we made and for exceeding our financial market expectations despite the continued market uncertainty. Both recognized revenues and annual recurring revenues ("ARR") grew by approximately 15% to $34.4m and $20.7m respectively. We remind shareholders that we are on a journey of transition from a traditional perpetual software license business to a higher-quality recurring revenue business. The goal is to deliver more predictable and reliable growth over the medium term; in the shorter term, this transition naturally weighs on profits as we accelerate go-to-market investment while simultaneously shifting software revenue recognition from an up-front to a rateable model. It was therefore very encouraging to also show continued profitability with both EBITDA and net cash growing. In addition to our financial results, 2021 was a year of unusually high activity and change for Sopheon. We appointed a new CEO, Greg Coticchia, and also strengthened our leadership team with appointments in key marketing, sales, and product areas. We have introduced and driven three key programs to support our strategic direction to:

 

· Transition our customer base and new sales engine to Software-as-a-Service ("SaaS"). By year end, 90 percent of the new customer pipeline by value was SaaS focused.

 

· Embrace a multi-product future by introducing new cloud-based applications. These new applications are intended to drive lead generation for our Accolade enterprise solution, as well as being stand-alone solutions that solve individual and workgroup productivity needs. At year end we completed the acquisition of ROI Blueprints, which is already playing a material role in both existing and new customer opportunities.

 

· Extend market reach beyond the very largest customers and thereby improve scalability and predictability. We made significant investments in marketing which are already increasing our metrics for market reach, prospect engagement and ultimately lead generation.

 

2022 update and outlook

 

Our most recent acquisition of Solverboard, announced in May 2022, accelerates our SaaS strategy from both functional and go-to-market perspectives. Solverboard's multi-tenant, SaaS product is used by both individual innovators and product professionals, and is sold using an online, product-led model. Solverboard brings the innovation and product needs of professionals together so that they can focus on addressing front-end innovation challenges, by helping companies dynamically find, align, test and deliver the best innovation and product ideas from employees and customers. We expect to further develop Solverboard's product sales led distribution capabilities and introduce additional Sopheon products to be sold through the Solverboard channel by the end of the year.

 

In parallel with our strategic progress, we have continued delivering growth in our core business. Since the start of the year, we have closed six new customer wins - compared to ten in the whole of 2021. All six were SaaS. ARR has risen to $21.7m compared to $19m a year ago, and gross retention has held above 98% on a year-to-date basis. These metrics demonstrate continued success with our transition towards a more recurring revenue model - which in turn improves our multi-year visibility and predictability. A lower share of one-off revenue contributions from perpetual and consulting sales year to date means that full year visibility for recognizable 2022 revenue is currently at $28m, a similar level to this time last year. Confidence in our full year performance is sustained by a sales pipeline that includes several major extensions with existing customers, alongside a growing list of new prospects. Net cash at the end of May stood at $25m compared to $23m at this time last year, underlining our cash generative nature and our ability to execute.

 

Sopheon's Chairman Andy Michuda said: "Sopheon's shift towards a pure play SaaS model and associated ARR growth is moving forward as planned, supported by delivery of two key acquisitions in ROI Blueprints and most recently Solverboard. We see growing commercial traction on both sides of the Atlantic, responding to our broader product offering and our more assertive marketing investment, and we remain focused on exploring other additive M&A opportunities."

 

For further information contact:

 

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)Alice Lane/Sunila da Silva (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

Sopheon, Accolade and Solverboard are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSRRDITIIF
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.